SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021145
Filing Date
2020-11-12
Accepted
2020-11-12 17:14:13
Documents
76
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1442421
2 ex31-1.htm EX-31.1 8562
3 ex31-2.htm EX-31.2 8331
4 ex32-1.htm EX-32.1 7497
  Complete submission text file 0001493152-20-021145.txt   5904935

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE qlgn-20200930.xml EX-101.INS 958627
6 XBRL SCHEMA FILE qlgn-20200930.xsd EX-101.SCH 76020
7 XBRL CALCULATION FILE qlgn-20200930_cal.xml EX-101.CAL 70948
8 XBRL DEFINITION FILE qlgn-20200930_def.xml EX-101.DEF 302211
9 XBRL LABEL FILE qlgn-20200930_lab.xml EX-101.LAB 476760
10 XBRL PRESENTATION FILE qlgn-20200930_pre.xml EX-101.PRE 377528
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 201307972
SIC: 2834 Pharmaceutical Preparations